The definitive directory of biotech venture capital and investment firms, spanning crossover and public-market funds, corporate venture arms, early-stage and seed VCs, global and European funds, growth equity, and company-creation firms. Curated for founders raising rounds, business development leads tracking capital, and LPs mapping managers.
BioMed Nexus tracks 147 biotech venture capital and investment firms across 7 categories: crossover & public, corporate VC, early stage & seed, global & EU, growth equity, multi-stage, and company creation. The directory covers the leading biotech investors, including Flagship Pioneering, ARCH Venture Partners, OrbiMed, Third Rock, RA Capital and Novo Holdings, alongside emerging funds. Last updated July 2026
Priority placement at the top of the directory, a dedicated landing page, and a featured newsletter segment reaching 65,000+ subscribers. Limited spots available.
Right now, every firm in this directory is just a name in a database. Featured partners get a full profile with logo, investment focus, portfolio highlights, backlinks, and priority placement at the very top of this page, seen by 65,000+ biotech professionals every week. Claim the top spot before your competitors do.
The BioMed Nexus Biotech Venture Capital & Investors Directory is a comprehensive, regularly updated list of investors funding the life sciences, spanning crossover and public-market funds, corporate venture capital arms of pharma companies, early-stage and seed VCs, global and European funds, growth equity firms, multi-stage generalists, and company-creation firms. It covers the most active biotech investors alongside emerging funds.
Use it to research biotech investors by stage and strategy, shortlist funding partners, and map the venture landscape. Whether you are a founder raising a round, a business development lead tracking capital, or an LP mapping managers, the directory provides structured, current firm data. Curated and maintained by the BioMed Nexus editorial team; last updated July 2026.
Firms can claim a free basic listing or become a Featured Partner for priority placement, a dedicated landing page, backlinks, and a featured segment in the BioMed Nexus daily newsletter reaching 65,000+ subscribers. Contact our partnerships team to learn more.
